Fact CheckerSign in

NCT07253909Enrolling by invitation

Upper Extremity Function in Patients With Reduced Ejection Fraction Heart Failure and Cardiac Implantable Electronic Devices

Investigation of Factors Determining Upper Extremity Function in Patients With Reduced Ejection Fraction Heart Failure and Cardiac Implantable Electronic Devices

Source: ClinicalTrials.gov · Last updated 28 Nov 2025

Brief summary (registry, in English)

The aim of this study is to evaluate in detail the factors that determine upper extremity function, determine its effect on prognosis, hospital admission, hospitalization, and mortality, and examine the results according to the use of different implantable cardiac implantable electronic devices.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
72 (estimated)
First submitted
19 Nov 2025
Start date
30 May 2025
Primary completion date
30 Aug 2026
Lead sponsor
Hacettepe University
NCT number
NCT07253909

What you commit to

  • Study type: Observational
  • Planned participants: 72
  • From 30 May 2025 to the primary completion date, 30 Aug 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with neurological, orthopedic, or psychiatric disorders,
  • History of shoulder surgery or shoulder injury,
  • Individuals with cognitive or mental disorders that would prevent them from understanding the tests administered in the study, or patients who are unwilling to participate

Who the study is looking for

  • Adults aged ≥18 years,
  • Left ventricular ejection fraction ≤40%,
  • Implanted cardiac defibrillator (ICD) or cardiac resynchronization therapy (CRT),
  • Diagnosed with heart failure,
  • No complications found during the last device check,
  • Clinically stable for the past month, with any accompanying chronic diseases (such as hypertension, diabetes) under control, and willing to participate in the study.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hacettepe University Faculty of Physical Therapy and Rehabilitation
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.